Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002;4(6):360-71.
doi: 10.1186/ar603. Epub 2002 Sep 25.

Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome

Affiliations
Review

Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome

Thomas Dörner et al. Arthritis Res. 2002.

Abstract

Primary Sjögren's syndrome (pSS) is an autoimmune disorder characterized by specific pathologic features and the production of typical autoantibodies. In addition, characteristic changes in the distribution of peripheral B cell subsets and differences in use of immunoglobulin variable-region genes are also features of pSS. Comparison of B cells from the blood and parotid gland of patients with pSS with those of normal donors suggests that there is a depletion of memory B cells from the peripheral blood and an accumulation or retention of these antigen-experienced B cells in the parotids. Because disordered selection leads to considerable differences in the B cell repertoire in these patients, the delineation of its nature should provide important further clues to the pathogenesis of this autoimmune inflammatory disorder.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis of the distribution of peripheral CD19+ B cell subsets demonstrates that patients with primary Sjögren's syndrome (pSS) have reduced frequencies of CD27+ memory B cells in the peripheral blood compared with normal donors. In addition, patients with pSS with secondary non-Hodgkin lymphoma exhibited an increase in CD27+ B cells in the blood.
Figure 2
Figure 2
Schematic distribution of B cell subsets in peripheral blood of normals compared with patients with systemic lupus erythematosus and Sjögren's syndrome.

Similar articles

Cited by

References

    1. Fox RI, Stern M, Michelson P. Update in Sjögren syndrome. Curr Opin Rheumatol. 2000;12:391–398. - PubMed
    1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. European Study Group on Classification Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis. 1996;55:116–121. - PMC - PubMed
    1. Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol. 1999;118:154. - PMC - PubMed
    1. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest. 1998;1102:938–946. - PMC - PubMed
    1. Bodeutsch C, deWilde PC, Kater L, van den Hoogen FH, Hene RJ, van Houwelingen JC, van de Putte LB, Vooijs GP. Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease. J Clin Pathol. 1993;46:123–128. - PMC - PubMed

Publication types

Substances